Baillie Gifford & Co’s Sana Biotechnology SANA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.5M | Sell |
10,064,728
-126,748
| -1% | -$346K | 0.02% | 175 |
|
|
2025
Q1 | $17.1M | Sell |
10,191,476
-42,097
| -0.4% | -$70.7K | 0.01% | 188 |
|
|
2024
Q4 | $16.7M | Sell |
10,233,573
-44,511
| -0.4% | -$72.6K | 0.01% | 190 |
|
|
2024
Q3 | $42.8M | Sell |
10,278,084
-293,116
| -3% | -$1.22M | 0.03% | 149 |
|
|
2024
Q2 | $57.7M | Sell |
10,571,200
-85,079
| -0.8% | -$465K | 0.05% | 135 |
|
|
2024
Q1 | $107M | Buy |
10,656,279
+506,262
| +5% | +$5.06M | 0.08% | 121 |
|
|
2023
Q4 | $41.4M | Sell |
10,150,017
-54,358
| -0.5% | -$222K | 0.03% | 157 |
|
|
2023
Q3 | $39.5M | Sell |
10,204,375
-631,786
| -6% | -$2.45M | 0.04% | 155 |
|
|
2023
Q2 | $64.6M | Sell |
10,836,161
-40,768
| -0.4% | -$243K | 0.05% | 137 |
|
|
2023
Q1 | $35.6M | Buy |
10,876,929
+112,202
| +1% | +$367K | 0.03% | 163 |
|
|
2022
Q4 | $42.5M | Sell |
10,764,727
-202,009
| -2% | -$798K | 0.04% | 151 |
|
|
2022
Q3 | $65.8M | Sell |
10,966,736
-44,726
| -0.4% | -$268K | 0.07% | 130 |
|
|
2022
Q2 | $70.8M | Sell |
11,011,462
-74,399
| -0.7% | -$478K | 0.07% | 137 |
|
|
2022
Q1 | $91.6M | Sell |
11,085,861
-176,169
| -2% | -$1.46M | 0.06% | 143 |
|
|
2021
Q4 | $174M | Buy |
11,262,030
+72,198
| +0.6% | +$1.12M | 0.1% | 115 |
|
|
2021
Q3 | $252M | Sell |
11,189,832
-52,019
| -0.5% | -$1.17M | 0.13% | 108 |
|
|
2021
Q2 | $221M | Buy |
11,241,851
+1,254,306
| +13% | +$24.7M | 0.11% | 121 |
|
|
2021
Q1 | $334M | Buy |
+9,987,545
| New | +$334M | 0.19% | 98 |
|